Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Single dose of azithromycin prevents recurrence of inturned eyelashes

14.03.2006


A Johns Hopkins Medicine study finds that a single dose of the oral antibiotic azithromycin taken after trichiasis eye surgery can reduce the frequency with which eyelashes turn back in and abrade the eye. The oral antibiotic treatment is more effective than multiple days of treatment with the topical antibiotic ointment Tetracycline, the current method of treatment after trichiasis surgery.



Trichiasis is the leading infectious cause of blindness worldwide. It is a condition in which the eyelid turns inward and the eyelashes rub against the eye, causing corneal scarring, that can lead to blindness. It results from years of repeated episodes of trachoma, an ocular bacterial infection that is very common in rural areas of developing countries.

The bacteria that cause trachoma are suspected to be spread by contact with hands or clothing of infected individuals. Flies may also transfer the infection from one person to another. Because trachoma is transmitted through close personal contact, it tends to occur in clusters, often infecting entire families and a large majority of people in a given community. The disease usually remains hidden in rural areas of developing countries where people live in overcrowded conditions with limited access to water and health care.


Trichiasis can be corrected by appropriate lid surgery, which returns the inturned eyelashes to their normal position. However, even under the best of circumstances the eyelashes may turn back in (between 16 percent and 50 percent within a few years after surgery). That’s why this new Johns Hopkins research is so valuable, says lead researcher Sheila West, Ph.D., of the Dana Center for Preventative Ophthalmology at Johns Hopkins Medicine. In the current study, less than 10 percent of people had their eyelid turn in again within one year after surgery.

In the study, published in the March 2006 issue of the Archives of Ophthalmology, the research team found that a single dose of the antibiotic azithromycin reduces the risk of trichiasis recurring for up to one year after surgery.

The researchers compared the use of one oral dose of azithromycin to six weeks of twice daily topical tetracycline treatment. Researchers found the azithromycin group had one-third fewer recurrences of inturned lashes than the tetracycline group.

"We are delighted with the results of this study. Trichiasis plagues the poorest of the poor, and primarily affects the most underprivileged members of the community, the women. The results of this study have major implications for improving outcomes of trichiasis surgery. The use of a single dose of azithromycin is a relatively straightforward and simple procedure to implement, and in many countries the drug is provided through a free donation program." says West. "Not only have we shown that azithromycin can reduce recurrence, but we have also demonstrated that in the hands of well-trained individuals trichiasis recurrence can be below 10 percent. These results set a new standard for trichiasis surgery and are applicable throughout the world."

John M. Lazarou | EurekAlert!
Further information:
http://www.jhmi.edu
http://www.hopkinsmedicine.org/wilmer/index.html
http://www.nei.nih.gov

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>